Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study

被引：26

作者：

Clift, Ashley Kieran ^{[1
]}

Saatci, Defne ^{[1
]}

Coupland, Carol A. C. ^{[2
]}

Dambha-Miller, Hajira ^{[3
]}

Hippisley-Cox, Julia ^{[1
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Univ Nottingham, Nottingham, England

[3] Univ Southampton, Southampton, Hants, England

来源：

ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 10期

基金：

英国医学研究理事会;

关键词：

D O I：

10.7326/M21-1375

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1483 / +

页数：5

共 4 条

[1] Sickle cell disease [J].

Kato, Gregory J. ;

Piel, Frederic B. ;

Reid, Clarice D. ;

Gaston, Marilyn H. ;

Ohene-Frempong, Kwaku ;

Krishnamurti, Lakshmanan ;

Smith, Wally R. ;

Panepinto, Julie A. ;

Weatherall, David J. ;

Costa, Fernando F. ;

Vichinsky, Elliott P. .

NATURE REVIEWS DISEASE PRIMERS, 2018, 4

[2] Intravascular hemolysis and the pathophysiology of sickle cell disease [J].

Kato, Gregory J. ;

Steinberg, Martin H. ;

Gladwin, Mark T. .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03) :750-760

[3] COVID-19 infection and sickle cell disease: a UK centre experience [J].

McCloskey, Kayleigh A. ;

Meenan, John ;

Hall, Rhys ;

Tsitsikas, Dimitris A. .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) :E57-E58

[4]

Panepinto JA, 2020, EMERG INFECT DIS, V26, P2473, DOI [10.3201/eid2610.201792, 10.3201/eid2610.202792]

← 1 →